Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression

NCT: NCT03653858 · COMPLETED

NCT IDNCT03653858
StatusCOMPLETED
Start Date2018-09-03
Completion2026-01-07

Brief Summary

The primary objective of this multicenter, randomized, sham-controlled, double blind (patient and observer blinded) clinical trial is to assess the antidepressant effect of Deep Brain Stimulation (DBS) in patients with treatment resistant major depression using the Boston Scientific implantable Vercise™ GEVIA™ DBS system compared to sham.

Frequently Asked Questions

What is Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression?

Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression is a clinical trial registered under NCT03653858. Current status: COMPLETED.

What is the status of NCT03653858?

The current status of NCT03653858 (Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression) is: COMPLETED.

When did Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression start?

Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression started on 2018-09-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑